Federated Hermes, Inc. 13D and 13G filings for Arcturus Therapeutics Holdings Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-17 2:43 pm Purchase |
2023-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT |
FEDERATED HERMES INC. FHI |
4,711,512 17.630% |
471,958 (+11.13%) |
Filing |
| 2023-02-01 10:11 am Purchase |
2022-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT |
FEDERATED HERMES INC. FHI |
4,239,554 16.000% |
544,625 (+14.74%) |
Filing |
| 2022-02-14 1:07 pm Purchase |
2021-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT |
FEDERATED HERMES INC. FHI |
3,694,929 14.020% |
242,119 (+7.01%) |
Filing |
| 2021-01-08 2:00 pm Purchase |
2020-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT |
FEDERATED HERMES INC. FHI |
3,452,810 13.350% |
3,452,810 (New Position) |
Filing |